Menu
Recruiting NCT06144164

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Phase III Interventional Lymphedema Lymphedema Arm Lymphedema of Upper Arm Breast Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Immediate Lymphatic Reconstruction, Volumetric arm measurements, Lymphatic massage, Range of motion exercises.
Who it may be relevant to
Registry conditions: Lymphedema, Lymphedema Arm, Lymphedema of Upper Arm, Breast Cancer. Basic parameters: 18 years — 75 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life

Overview

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

Interventions

  • Procedure Immediate Lymphatic Reconstruction
    Immediate Lymphatic Reconstruction will happen at the time of Axillary Lymph Node Dissection
  • Diagnostic test Volumetric arm measurements
    Volumetric arm measurements will occur at each in-person postoperative visit time points.
  • Other Lymphatic massage
    Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
  • Other Range of motion exercises
    Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
  • Other Compression garment use
    Participants will use compression garments 24 to 48 h after surgery and will continue daily use for at least 8 h a day for 3 months or until 3 months after any adjuvant treatments are completed

Primary outcome measures

  • The difference between the baseline and postoperative arm volume measurement [Time frame: Up to 24 months]

Eligibility criteria

Inclusion criteria

  • Female sex
  • Diagnosis of breast cancer
  • Ages 18 to 75 years
  • Consented for unilateral ALND or for unilateral SLNB with possible ALND

Exclusion criteria

  • Male sex
  • Does not speak English
  • Does not fit into study garment
  • Axillary recurrence
  • History of ALND
  • Requirement of bilateral ALND for the treatment of breast cancer
  • Treatment with SLNB only
  • Known anaphylactic allergy to ICG dye used in ILR
  • Impaired decision-making capacity

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 7 centers
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) — Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities) — Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities) — Uniondale

Identifiers

NCT: NCT06144164 · 23-303

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗